1. Home
  2. FTK vs ORIC Comparison

FTK vs ORIC Comparison

Compare FTK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Flotek Industries Inc.

FTK

Flotek Industries Inc.

HOLD

Current Price

$24.11

Market Cap

720.7M

Sector

Industrials

ML Signal

HOLD

Logo Oric Pharmaceuticals Inc.

ORIC

Oric Pharmaceuticals Inc.

HOLD

Current Price

$7.79

Market Cap

861.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTK
ORIC
Founded
1985
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
720.7M
861.3M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
FTK
ORIC
Price
$24.11
$7.79
Analyst Decision
Buy
Strong Buy
Analyst Count
1
13
Target Price
$20.00
$19.73
AVG Volume (30 Days)
323.4K
1.5M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
147.06
19.67
EPS
0.12
N/A
Revenue
$136,092,000.00
N/A
Revenue This Year
$13.33
N/A
Revenue Next Year
$16.38
N/A
P/E Ratio
$196.25
N/A
Revenue Growth
214.53
N/A
52 Week Low
$10.96
$7.23
52 Week High
$25.54
$14.93

Technical Indicators

Market Signals
Indicator
FTK
ORIC
Relative Strength Index (RSI) 69.72 41.43
Support Level $15.01 $7.68
Resistance Level N/A $9.13
Average True Range (ATR) 1.54 0.52
MACD 0.29 -0.01
Stochastic Oscillator 76.71 27.84

Price Performance

Historical Comparison
FTK
ORIC

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

Share on Social Networks: